AFG
American Financial Group’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $135K | Hold |
10,105
| – | – | 0.05% | 58 |
|
|
2025
Q1 | $103K | Hold |
10,105
| – | – | 0.04% | 57 |
|
|
2024
Q4 | $160K | Hold |
10,105
| – | – | 0.07% | 57 |
|
|
2024
Q3 | $587K | Hold |
10,105
| – | – | 0.25% | 51 |
|
|
2024
Q2 | $462K | Hold |
10,105
| – | – | 0.2% | 53 |
|
|
2024
Q1 | $669K | Hold |
10,105
| – | – | 0.25% | 52 |
|
|
2023
Q4 | $402K | Hold |
10,105
| – | – | 0.15% | 63 |
|
|
2023
Q3 | $322K | Hold |
10,105
| – | – | 0.11% | 71 |
|
|
2023
Q2 | $406K | Hold |
10,105
| – | – | 0.13% | 72 |
|
|
2023
Q1 | $431K | Hold |
10,105
| – | – | 0.13% | 71 |
|
|
2022
Q4 | $485K | Hold |
10,105
| – | – | 0.16% | 72 |
|
|
2022
Q3 | $380K | Hold |
10,105
| – | – | 0.13% | 76 |
|
|
2022
Q2 | $279K | Hold |
10,105
| – | – | 0.09% | 81 |
|
|
2022
Q1 | $550K | Hold |
10,105
| – | – | 0.17% | 69 |
|
|
2021
Q4 | $591K | Hold |
10,105
| – | – | 0.16% | 67 |
|
|
2021
Q3 | $400K | Hold |
10,105
| – | – | 0.11% | 76 |
|
|
2021
Q2 | $429K | Buy |
+10,105
| New | +$429K | 0.11% | 72 |
|